Pfizer CEO Albert Bourla
CNN
Pfizer CEO Albert Bourla
Now playing
04:05
Dr. Gupta talks to Pfizer CEO about vaccine effectiveness
courtesy TytoCare
Now playing
04:04
How these telemedicine companies are innovating in the pandemic
2 Jul 2000:  A view of the court WNBA Logo taken before a game between the Los Angeles Sparks and the Detroit Shock at the Great Western Forum in Inglewood, California.  The Sparks defeated the Shock 85-63. NOTE TO USER: It is expressly understood that the only rights Allsport are offering to license in this Photograph are one-time, non-exclusive editorial rights. No advertising or commercial uses of any kind may be made of Allsport photos. User acknowledges that it is aware that Allsport is an editorial sports agency and that NO RELEASES OF ANY TYPE ARE OBTAINED from the subjects contained in the photographs.Mandatory Credit: Danny Moloshok  /Allsport
Danny Moloshok/Getty Images North America/Getty Images
2 Jul 2000: A view of the court WNBA Logo taken before a game between the Los Angeles Sparks and the Detroit Shock at the Great Western Forum in Inglewood, California. The Sparks defeated the Shock 85-63. NOTE TO USER: It is expressly understood that the only rights Allsport are offering to license in this Photograph are one-time, non-exclusive editorial rights. No advertising or commercial uses of any kind may be made of Allsport photos. User acknowledges that it is aware that Allsport is an editorial sports agency and that NO RELEASES OF ANY TYPE ARE OBTAINED from the subjects contained in the photographs.Mandatory Credit: Danny Moloshok /Allsport
Now playing
02:52
This pro sports league is 99% vaccinated. Hear how it was done
Now playing
02:14
Remote or office work? The strategies are varied
Now playing
03:53
Royal Caribbean Cruises CEO: Crew will serve the buffet
Now playing
02:17
Wedding planner: There's panic-booking happening right now
CNN
Now playing
02:45
Cities debate future of outdoor dining post-pandemic
Signage outside of Morgan Stanley headquarters in New York, U.S., on Friday, April 9, 2021. Morgan Stanley is scheduled to release earnings figures on April 16. Photographer: Jeenah Moon/Bloomberg via Getty Images
Jeenah Moon/Bloomberg/Getty Images
Signage outside of Morgan Stanley headquarters in New York, U.S., on Friday, April 9, 2021. Morgan Stanley is scheduled to release earnings figures on April 16. Photographer: Jeenah Moon/Bloomberg via Getty Images
Now playing
02:56
Wall Street wants employees back in the office
Now playing
02:51
Childcare worker shortages, waitlists - parents face hurdles returning to work
Now playing
03:00
Stew Leonard's CEO: Meat prices are at record high levels
CNN
Now playing
02:57
Live concerts signal a return to pre-pandemic normalcy
Now playing
03:56
Live Nation president: We're seeing massive demand for concerts
iStock
Now playing
02:05
Tips to keep rising wedding costs down
Photo: iStock
iStock
Photo: iStock
Now playing
02:15
LL Bean CEO: People are dressing up, but not giving up comfort
Carnival Breeze in Galveston, Texas, on May 2, 2021.
Courtesy @mikewelsch
Carnival Breeze in Galveston, Texas, on May 2, 2021.
Now playing
03:02
Carnival gets CDC approval to restart US cruises
Now playing
02:59
US trucker shortage means everything is more expensive
New York CNN Business —  

Pfizer CEO Albert Bourla filed to sell millions of dollars of his company’s stock Monday – the day the pharmaceutical giant announced positive data about its coronavirus vaccine.

The company’s shares soared after Pfizer and European drug company BioNTech said early data suggests the vaccine could be more than 90% effective.

The transaction was part of a regularly scheduled plan set up by Bourla to periodically sell some of his Pfizer shares.

Bourla sold 132,508 Pfizer (PFE) shares at a price of $41.94, according to a filing with the Securities and Exchange Commission. That works out to proceeds of nearly $5.6 million.

A Pfizer spokeswoman said in an email to CNN Business that the sale took place because Pfizer shares hit a predetermined price as part of a plan authorized by Bourla on August 19.

When asked if Pfizer and Bourla thought to cancel the stock sale due to the perception that Bourla might be cashing in on good news, the spokeswoman said that “these are predetermined plans managed through a third-party stock administrator.”

Another Pfizer officer, executive vice president Sally Susman, also sold shares Monday as part of a prearranged plan. Susman sold 43,662 shares at the same $41.94 price that Bourla sold at, a transaction valued at more than $1.8 million.

Many executives sell stock at predetermined intervals to diversify their portfolios. But they can delay the sales to avoid appearances of capitalizing on one-off events that can boost company’s shares.

Bouria told CNN’s Sanjay Gupta that he learned of the trial’s results Sunday, a day before they were made public.

Shares of Pfizer surged nearly 8% Monday and were flat Tuesday. BioNTech’s (BNTX)stock has rallied even more sharply, rising 15% Monday and another 8% Tuesday. Pfizer’s stock fell more than 1% Wednesday.

The Pfizer stock sale comes just a few months after executives at Moderna (MRNA), a biotech also working on a Covid-19 vaccine, sold shares following the release of promising trial results.

Critics accused Moderna of overhyping the vaccine trial results, but the company nonetheless raised $1.3 billion in a stock sale immediately following the vaccine trial announcement.

Executives then sold tens of millions of dollars worth of Moderna shares before the company’s stock price fizzled a week later.

Some former SEC officials called on Moderna to be investigated for potential illegal market manipulation.